DNAnexus Platform Exceeds Online Security Standards in President Biden’s Executive Order Aimed at Protecting American Infrastructure from Cyberattacks

DNAnexus platform exceeds online security policy objectives outlined in President Biden’s executive order protecting American infrastructure from cyberattacks

FDB Launches Clinical Decision Support Analytics Solution

FDB Launches Clinical Decision Support Analytics Solution

Lightbeam Health Solutions Announces Partnership with Genetic Testing Company, Ambry Genetics

Lightbeam Health Solutions Announces Partnership with Genetic Testing Company, Ambry Genetics

Heraeus completes multi-million Euro cancer therapy API capacity expansion

Heraeus Pharmaceutical Ingredients’ additional production line for Platinum-based highly potent active pharmaceutical ingredients (Pt hAPIs) is now fully operational at the company’s headquarters in Hanau, Germany.

Dotmatics to deliver the foundation for Croda’s R&D digital program: artificial intelligence and data mining

For further information on Dotmatics, please visit www.dotmatics.com

Quanticate appoints new Head of Machine Learning and Digital Transformation

Quanticate, a leading global data-focused Clinical Research Organization (CRO), has named Piotr Karasiewicz as the company's new Head of Machine Learning and Digital Transformation to lead process improvements and ensure efficient and high-quality data analysis.

1upHealth Announces Free Baseline Testing for Health Plans to Determine if their Patient Access FHIR® API is Successfully Connecting as Required by CMS

ADVANZ PHARMA partners with Ashfield Engage to deliver talent acquisition strategy for European specialty medicine division

Ashfield Engage, part of UDG Healthcare plc, announced that it has partnered with ADVANZ PHARMA to develop and deliver a pan-European talent acquisition programme for ADVANZ PHARMA’s specialty medicine division.

Panthera steps up its move into oncology trials with more than 12 trials in the pipeline and a prostate trial underway

Many cancer clinical research trials were put on hold during Covid – now Panthera Biopartners and Rutherford Health are working in partnership to accelerate oncology research in order to provide improved care for patients.

Qlucore and Clarivate partner to provide researchers with powerful and flexible omics data analysis and visualization

Researchers will be able to make faster and more accurate analysis of experiment data with a workflow powered by Qlucore Omics Explorer and MetaCore™, a Cortellis™ solution.

StageZero Life Sciences Signs Definitive Agreement with Health Clinics Limited

StageZero Life Sciences, the company that created the first-ever test that simultaneously screens for multiple cancers from a single sample of blood, has acquired Care Oncology. Care Oncology has clinics in California, telehealth practices in all 50 states and provides treatments that complement and enhance the effect of standard-of-care cancer therapies. This acquisition expands StageZero’s clinical offerings, including access to a robust network of oncologists and physicians across the U.S.

Partek and Agilent Partner to Deliver Alissa Customers End-to-End Bioinformatics Workflow: Delivering flexible and customizable secondary analysis and disease diagnoses for the clinical setting

Partek® Flow® bioinformatics software to be integrated into Agilent Alissa Clinical Informatics Platform to deliver a complete end-to-end analysis.

King Abdullah University of Science & Technology Joins Kerafast as 200th Providing Institution

Pluto Biosciences Launches Cloud-based Collaborative Life Sciences Platform for Academia, Biotech and Pharma Organizations

Pluto, a Denver-based biotech software startup, launched it's secure, collaborative life sciences platform to be the digital lab space for life sciences teams of all sizes, anywhere in the world. The Pluto platform leverages technology developed at Harvard's Wyss Institute and simplifies secure, collaborative data sharing and bioinformatics analysis for academic, biotech, and pharmaceutical organizations, enabling them to make discoveries faster and more efficiently.

Sensyne Health and Sentara Healthcare Form New Partnership for Ethical Data Sharing and Design of New Clinical Algorithms

Rho to Coordinate Study Sponsored by NIAID to Assess Systemic Allergic Reactions to Pfizer and Moderna COVID-19 Vaccines

Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced it is coordinating a study called Systemic Allergic Reactions to SARS-CoV-2 Vaccination to assess the proportion of participants with a systemic allergic reaction to the Pfizer-BioNTech and Moderna COVID-19 vaccines in populations at high risk for allergic reaction compared to a general population. This research will be important for further understanding potential risk factors for an allergic reaction to these particular vaccines, as well as to future vaccines that similarly use an mRNA nanoparticle platform. The study is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

Bruker Announces New Microbiology Products and Workflows for Microbial Identification and Infection Control at ECCMID 2021

QCI and IPQ Partner on Novel Approach to Drive More Effective Clinical Trials and Diagnostic Outcomes

Quantum Computing Inc. (QCI) (OTCQB: QUBT), the leader in bridging the power of classical and quantum computing, has announced a partnership with IPQ Analytics, LLC (IPQ), a life sciences and healthcare analytics innovator that provides a new breed of solutions for improved diagnostics and clinical trial outcomes. Through the partnership, IPQ will analyze real world data to generate novel temporally-defined disease models by combining its unique top-down knowledge graph representation of the patient journey with QCI’s quantum-powered community detection technology.

WCG Acquires Intrinsic Imaging, Leading Full-Service Medical Imaging Core Lab

Acquisition Enriches WCG’s Scientific and Regulatory Capabilities with Comprehensive Services Ensuring Quality and Validity of Clinical Trial Results Across Drug, Medical Device and Artificial Intelligence Studie

Idifarma launches accelerated pathway for complex drugs